scholarly article | Q13442814 |
P356 | DOI | 10.1002/1522-2594(200103)45:3<397::AID-MRM1052>3.0.CO;2-3 |
P698 | PubMed publication ID | 11241696 |
P2093 | author name string | M Décorps | |
C Julien | |||
I Troprès | |||
L Lamalle | |||
J F Payen | |||
E Grillon | |||
A Vaeth | |||
S Grimault | |||
P433 | issue | 3 | |
P304 | page(s) | 397-408 | |
P577 | publication date | 2001-03-01 | |
P1433 | published in | Magnetic Resonance in Medicine | Q6731496 |
P1476 | title | Vessel size imaging | |
P478 | volume | 45 |
Q38741691 | A Population-Based Digital Reference Object (DRO) for Optimizing Dynamic Susceptibility Contrast (DSC)-MRI Methods for Clinical Trials |
Q51873935 | A computational framework for modelling solid tumour growth. |
Q31049099 | A new Magnetic Resonance Imaging method for mapping the cerebral blood volume fraction: the rapid steady-state T1 method |
Q38901931 | A simplified spin and gradient echo approach for brain tumor perfusion imaging |
Q33727635 | A theoretical framework for determining cerebral vascular function and heterogeneity from dynamic susceptibility contrast MRI |
Q37749573 | Anatomical and microstructural imaging of angiogenesis. |
Q48332902 | Arterial versus total blood volume changes during neural activity-induced cerebral blood flow change: implication for BOLD fMRI. |
Q39229419 | Assessing breast cancer angiogenesis in vivo: which susceptibility contrast MRI biomarkers are relevant? |
Q33587272 | Assessment of Blood Hemodynamics by USPIO-Induced R(1) Changes in MRI of Murine Colon Carcinoma |
Q42112303 | Assessment of a combined spin- and gradient-echo (SAGE) DSC-MRI method for preclinical neuroimaging |
Q39560369 | Assessment of a simplified spin and gradient echo (sSAGE) approach for human brain tumor perfusion imaging |
Q52714281 | Assessment of the direct effects of DDAH I on tumour angiogenesis in vivo. |
Q36695323 | Assessment of vascular reactivity in rat brain glioma by measuring regional blood volume during graded hypoxic hypoxia |
Q39171896 | Blood oxygenation level dependent, blood volume, and blood flow responses to carbogen and hypoxic hypoxia in 9L rat gliomas as measured by MRI. |
Q48585552 | Carbogen-induced increases in tumor oxygenation depend on the vascular status of the tumor: A multiparametric MRI study in two rat glioblastoma models. |
Q30580013 | Cerebral blood volume MRI with intravascular superparamagnetic iron oxide nanoparticles. |
Q48638550 | Cerebral blood volume estimation by ferumoxytol-enhanced steady-state MRI at 9.4 T reveals microvascular impact of α1 -adrenergic receptor antibodies. |
Q38805357 | Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRI. |
Q62269597 | Characterization of late radiation effects in the rat thoracolumbar spinal cord by MR imaging using USPIO |
Q43447982 | Characterization of the 9L gliosarcoma implanted in the Fischer rat: an orthotopic model for a grade IV brain tumor. |
Q39966046 | Clinical translation of ferumoxytol-based vessel size imaging (VSI): Feasibility in a phase I oncology clinical trial population |
Q36031027 | Combined spin- and gradient-echo perfusion-weighted imaging. |
Q33898480 | Comparative analysis of arterial spin labeling and dynamic susceptibility contrast perfusion imaging for quantitative perfusion measurements of brain tumors |
Q47387857 | Comparison of ferumoxytol-based cerebral blood volume estimates using quantitative R1 and R2* relaxometry |
Q35631757 | Compensation of slice profile mismatch in combined spin- and gradient-echo echo-planar imaging pulse sequences |
Q47392014 | Concurrent MR blood volume and vessel size estimation in tumors by robust and simultaneous ΔR2 and ΔR2* quantification |
Q57696930 | Contrast agents for MRI based on iron oxide nanoparticles prepared by laser pyrolysis |
Q51431393 | Contrast-enhanced magnetic resonance microangiography reveals remodeling of the cerebral microvasculature in transgenic ArcAβ mice. |
Q41850755 | Contributions of dynamic venous blood volume versus oxygenation level changes to BOLD fMRI |
Q33286035 | Correlation of MRI biomarkers with tumor necrosis in Hras5 tumor xenograft in athymic rats |
Q38181079 | Could magnetic resonance provide in vivo histology? |
Q30234702 | Current and potential imaging applications of ferumoxytol for magnetic resonance imaging. |
Q74035878 | Current awareness |
Q38376846 | Difference in the intratumoral distributions of extracellular-fluid and intravascular MR contrast agents in glioblastoma growth |
Q41942432 | Dispersion of relaxation rates in the rotating frame under the action of spin-locking pulses and diffusion in inhomogeneous magnetic fields |
Q38168371 | Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments. |
Q41559635 | Dynamic contrast-enhanced magnetic resonance imaging rapidly indicates vessel regression in human squamous cell carcinomas grown in nude mice caused by VEGF receptor 2 blockade with DC101. |
Q48501713 | Dynamic hysteresis between gradient echo and spin echo attenuations in dynamic susceptibility contrast imaging. |
Q46869122 | Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas |
Q53235328 | Erratum to: Ungersma SE, Pacheco G, Ho C, Yee SF, Ross J, van Bruggen N, Peale FV Jr, Ross S, Carano RA. Vessel imaging with viable tumor analysis for quantification of tumor angiogenesis. Magn Reson Med 2010;63:1637–1647. |
Q57931565 | Estimation of microvascular capillary physical parameters using MRI assuming a pseudo liquid drop as model of fluid exchange on the cellular level |
Q34619841 | Evaluation of a multiple spin- and gradient-echo (SAGE) EPI acquisition with SENSE acceleration: applications for perfusion imaging in and outside the brain |
Q48669111 | Feasibility study of exploring a T₁-weighted dynamic contrast-enhanced MR approach for brain perfusion imaging |
Q38314429 | Functional MRI and CT biomarkers in oncology |
Q39426995 | GESFIDE-PROPELLER approach for simultaneous R2 and R2* measurements in the abdomen |
Q35312455 | High-field small animal magnetic resonance oncology studies. |
Q46842885 | High-resolution cerebral blood volume imaging in humans using the blood pool contrast agent ferumoxytol. |
Q39588794 | Histogram analysis of the microvasculature of intracerebral human and murine glioma xenografts |
Q35800491 | How stereological analysis of vascular morphology can quantify the blood volume fraction as a marker for tumor vasculature: comparison with magnetic resonance imaging |
Q38198632 | Imaging of cerebrovascular pathology in animal models of Alzheimer's disease |
Q38244289 | Imaging the microvessel caliber and density: Principles and applications of microvascular MRI. |
Q88576622 | Imaging vascular and hemodynamic features of the brain using dynamic susceptibility contrast and dynamic contrast enhanced MRI |
Q43980822 | In vivo imaging of vessel diameter, size, and density: a comparative study between MRI and histology |
Q34420720 | In vivo measurement of volumetric strain in the human brain induced by arterial pulsation and harmonic waves |
Q34132818 | In vivo validation of MRI vessel caliber index measurement methods with intravital optical microscopy in a U87 mouse brain tumor model |
Q33900712 | In-vivo visualization of tumor microvessel density and response to anti-angiogenic treatment by high resolution MRI in mice |
Q26999069 | Integrative analysis of cancer imaging readouts by networks |
Q48872237 | Intravenous Injection of Clinical Grade Human MSCs After Experimental Stroke: Functional Benefit and Microvascular Effect. |
Q31133294 | Investigating intracranial tumour growth patterns with multiparametric MRI incorporating Gd-DTPA and USPIO-enhanced imaging |
Q33816112 | Investigating temporal fluctuations in tumor vasculature with combined carbogen and ultrasmall superparamagnetic iron oxide particle (CUSPIO) imaging. |
Q37347403 | Investigating the Vascular Phenotype of Subcutaneously and Orthotopically Propagated PC3 Prostate Cancer Xenografts Using Combined Carbogen Ultrasmall Superparamagnetic Iron Oxide MRI. |
Q38804591 | Investigating the role of tumour cell derived iNOS on tumour growth and vasculature in vivo using a tetracycline regulated expression system |
Q35700926 | Is T2* enough to assess oxygenation? Quantitative blood oxygen level-dependent analysis in brain tumor. |
Q36011821 | Is optical imaging spectroscopy a viable measurement technique for the investigation of the negative BOLD phenomenon? A concurrent optical imaging spectroscopy and fMRI study at high field (7 T). |
Q37662741 | Layer-dependent BOLD and CBV-weighted fMRI responses in the rat olfactory bulb |
Q42267582 | Longitudinal studies of angiogenesis in hormone-dependent Shionogi tumors |
Q37435184 | MR Vascular Fingerprinting in Stroke and Brain Tumors Models |
Q31110396 | MR and CT perfusion imaging of the brain: principles and clinical applications |
Q47405585 | MR evaluation of vessel size imaging of human gliomas: Validation by histopathology |
Q30711812 | MR vascular fingerprinting: A new approach to compute cerebral blood volume, mean vessel radius, and oxygenation maps in the human brain |
Q90471544 | MRI Visualization of Whole Brain Macro- and Microvascular Remodeling in a Rat Model of Ischemic Stroke: A Pilot Study |
Q36852895 | MRI measurements of vessel calibre in tumour xenografts: comparison with vascular corrosion casting |
Q33605839 | Magnetic resonance imaging of brain angiogenesis after stroke |
Q33883070 | Magnetic resonance in the era of molecular imaging of cancer |
Q33794091 | Mean microvessel segment length and radius after embolic stroke: Comparison of magnetic resonance imaging (MRI) and laser scanning confocal microscopy (LSCM) |
Q39172977 | Mesoscopic imaging of glioblastomas: Are diffusion, perfusion and spectroscopic measures influenced by the radiogenetic phenotype? |
Q30643023 | Methodology of brain perfusion imaging |
Q38992908 | Microvascular MRI and unsupervised clustering yields histology-resembling images in two rat models of glioma. |
Q48409029 | Microvascular cerebral blood volume changes in aging APP(swe)/PS1(dE9) AD mouse model: a voxel-wise approach. |
Q28384680 | Multimodal microvascular imaging reveals that selective inhibition of class I PI3K is sufficient to induce an antivascular response |
Q53829611 | Multiparametric MRI as an early biomarker of individual therapy effects during concomitant treatment of brain tumours. |
Q48599343 | Multiparametric magnetic resonance imaging including oxygenation mapping of experimental ischaemic stroke. |
Q39005705 | Multiscale and multi-modality visualization of angiogenesis in a human breast cancer model |
Q30653662 | Neurovascular abnormalities in brain disorders: highlights with angiogenesis and magnetic resonance imaging studies |
Q39882797 | No increase of the blood oxygenation level-dependent functional magnetic resonance imaging signal with higher field strength: implications for brain activation studies |
Q36739621 | Non-invasive assessment of vessel morphology and function in tumors by magnetic resonance imaging |
Q37346178 | Noninvasive Assessment of Losartan-Induced Increase in Functional Microvasculature and Drug Delivery in Pancreatic Ductal Adenocarcinoma |
Q37722760 | Numerical modeling of susceptibility-related MR signal dephasing with vessel size measurement: phantom validation at 3T. |
Q49026555 | On the theoretical basis of perfusion measurements by dynamic susceptibility contrast MRI. |
Q39218077 | Pattern analysis accounts for heterogeneity observed in MRI studies of tumor angiogenesis |
Q31044410 | Perfusion MR imaging in brain tumors |
Q37063506 | Perfusion measurement using DCE-MRI: implications for hyperthermia |
Q91564975 | Perfusion weighted imaging using combined gradient/spin echo EPIK: Brain tumour applications in hybrid MR-PET |
Q37487052 | Potential of compressed sensing in quantitative MR imaging of cancer. |
Q44064342 | Quantification of venous vessel size in human brain in response to hypercapnia and hyperoxia using magnetic resonance imaging |
Q34106364 | Quantitative MR estimates of blood oxygenation based on T2*: a numerical study of the impact of model assumptions |
Q40344641 | Quantitative MRI of cerebral arterial blood volume |
Q33969302 | Quantitative phenomenological model of the BOLD contrast mechanism. |
Q47254629 | Quantitative vascular neuroimaging of the rat brain using superparamagnetic nanoparticles: New insights on vascular organization and brain function |
Q36522707 | Quantitative β mapping for calibrated fMRI. |
Q30491884 | Refinement of optical imaging spectroscopy algorithms using concurrent BOLD and CBV fMRI. |
Q28742242 | Sensitivity of MRI tumor biomarkers to VEGFR inhibitor therapy in an orthotopic mouse glioma model |
Q48853987 | Simultaneous dynamic R2 R2', and R2* measurement using periodic π pulse shifting multiecho asymmetric spin echo sequence moving estimation strategy: A feasibility study for lower extremity muscle |
Q30930089 | Simultaneous evaluation of vascular morphology, blood volume and transvascular permeability using SPION-based, dual-contrast MRI: imaging optimization and feasibility test |
Q36839996 | Simultaneous perfusion and permeability measurements using combined spin- and gradient-echo MRI |
Q85072202 | Sorafenib tosylate and paclitaxel induce anti-angiogenic, anti-tumour and anti-resorptive effects in experimental breast cancer bone metastases |
Q55456663 | Spatiotemporal heterogeneity of tumor vasculature during tumor growth and antiangiogenic treatment: MRI assessment using permeability and blood volume parameters. |
Q42446830 | Spin-echo echo-planar perfusion MR imaging in the differential diagnosis of solitary enhancing brain lesions: distinguishing solitary metastases from primary glioma |
Q42844943 | The influence of noise on BOLD-mediated vessel size imaging analysis methods |
Q36376393 | The larmor frequency shift in magnetically heterogeneous media depends on their mesoscopic structure |
Q30665074 | The physics of functional magnetic resonance imaging (fMRI). |
Q47326026 | The potential of microvessel density in prediction of infarct growth: a two-month experimental study in vessel size imaging |
Q37187098 | The role of clinical imaging in oncological drug development |
Q42870267 | Tissue oxygen saturation mapping with magnetic resonance imaging. |
Q89049616 | Transverse NMR relaxation in biological tissues |
Q43376100 | Use of Ultrasmall Superparamagnetic Iron Oxide Enhanced Susceptibility Weighted Imaging and Mean Vessel Density Imaging to Monitor Antiangiogenic Effects of Sorafenib on Experimental Hepatocellular Carcinoma |
Q26865120 | Using magnetic resonance imaging and spectroscopy in cancer diagnostics and monitoring: preclinical and clinical approaches |
Q62745891 | Validation of vessel size imaging (VSI) in high-grade human gliomas using magnetic resonance imaging, image-guided biopsies, and quantitative immunohistochemistry |
Q57603326 | Vascular changes after stroke in the rat: a longitudinal study using optimized magnetic resonance imaging |
Q44415257 | Vascular endothelial growth factor-A determines detectability of experimental melanoma brain metastasis in GD-DTPA-enhanced MRI. |
Q35196265 | Vasculature-specific MRI reveals differential anti-angiogenic effects of a biomimetic peptide in an orthotopic breast cancer model |
Q92524376 | Vessel architecture imaging using multiband gradient-echo/spin-echo EPI |
Q30651792 | Vessel caliber--a potential MRI biomarker of tumour response in clinical trials. |
Q87871487 | Vessel radius mapping in an extended model of transverse relaxation |
Q35208012 | Vessel size imaging reveals pathological changes of microvessel density and size in acute ischemia |
Q40484546 | Vessel size imaging using low intravascular contrast agent concentrations |
Q39507583 | Vessel size index measurements in a rat model of glioma: comparison of the dynamic (Gd) and steady-state (iron-oxide) susceptibility contrast MRI approaches |
Q53399361 | [Modern magnetic resonance procedures for assessing tumor response]. |
Q53563281 | [Perfusion MR imaging for initial diagnosis and follow-up of brain tumors] |
Search more.